NewsBenzingaC4 Therapeutics在第23届IMS年会上发布了Cemsidomide与地塞米松联合治疗复发性多发性骨髓瘤患者的一期临床试验中的新生物标志数据 C4 Therapeutics在第23届IMS年会上发布了Cemsidomide与地塞米松联合治疗复发性多发性骨髓瘤患者的一期临床试验中的新生物标志数据 Benzinga 2026.09.25 11:02 (GMT+0) Open on Benzinga Other news ServiceNow, Eaton, SentinelOne And A Financial Stock: CNBC’s ‘Final Trades’ Top Wall Street Forecasters Revamp Abbott Expectations Ahead Of Q3 Earnings Centrus Energy Acquires Westerman Holdings For ~$116M, Funded Through Combination Of ~$95M Cash On Hand And $21M Of Equity Curaleaf Cites Aurora Board's Fiduciary Duty Regarding Previously Recommended Shareholder Rejection Of Curaleaf's Enhanced Proposal Rekor Systems Files Verified Complaint In Delaware Chancery Court Against Former Director Viraj Mehta Alleging Breach Of Fiduciary Duty Of Loyalty In Connection With The Company’s December 2025 Financing Tonix Pharmaceuticals To Present Effects Of TONMYA On Fibromyalgia Symptoms And Physical Function At The World Congress On Pain, October 26-30
Centrus Energy Acquires Westerman Holdings For ~$116M, Funded Through Combination Of ~$95M Cash On Hand And $21M Of Equity
Curaleaf Cites Aurora Board's Fiduciary Duty Regarding Previously Recommended Shareholder Rejection Of Curaleaf's Enhanced Proposal
Rekor Systems Files Verified Complaint In Delaware Chancery Court Against Former Director Viraj Mehta Alleging Breach Of Fiduciary Duty Of Loyalty In Connection With The Company’s December 2025 Financing
Tonix Pharmaceuticals To Present Effects Of TONMYA On Fibromyalgia Symptoms And Physical Function At The World Congress On Pain, October 26-30
